Trial Profile
A phase II trial of omadacycline for the treatment of complicated urinary tract infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary)
- Indications Pyelonephritis
- Focus Proof of concept; Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 03 Jan 2018 According to a Paratek Pharmaceuticals media release, company plans to initiate this trial later in 2018.
- 03 Apr 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment as early as December of 2017.
- 08 Feb 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment in the fourth quarter of 2017.